Benefits of tailored hepatocellular carcinoma screening in patients with cirrhosis on cancer‐specific and overall mortality: A modeling approach

Benefits of tailored hepatocellular carcinoma screening in patients with cirrhosis on cancer‐specific and overall mortality: A modeling approach

Abstract To validate cancer screening programs, experts recommend estimating effects on case fatality rates (CFRs) and cancer‐specific mortality. This study evaluates hepatocellular carcinoma (HCC) screening in patients with cirrhosis for those outcomes using a modeling approach. We designed a Marko...

Full description

Bibliographic Details
Main Authors: Massih Ningarhari, Abbas Mourad, Claire Delacôte, Line‐Carolle Ntandja Wandji, Guillaume Lassailly, Alexandre Louvet, Sébastien Dharancy, Philippe Mathurin, Sylvie Deuffic‐Burban
Format: Article
Language:English
Published: Wolters Kluwer Health/LWW 2022-10-01
Series:Hepatology Communications
Online Access:https://doi.org/10.1002/hep4.2059

Internet

https://doi.org/10.1002/hep4.2059

Similar Items